Preparation method and application of metal organic framework immobilized ligase

The immobilized ligase mutant Q186G/S328A, encapsulated in ZIF-8, solves the problems of low catalytic efficiency and poor stability in aspartame synthesis, enabling efficient and simplified α-AMP synthesis and reusable enzymes, suitable for the industrial production of aspartame.

CN121380046APending Publication Date: 2026-01-23SUZHOU ZHENTAI BIOTECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202511752744.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-11-26
Publication Date
2026-01-23

AI Technical Summary

Technical Problem

In existing technologies, the traditional chemical synthesis route of aspartame is lengthy and produces tasteless β-isomer byproducts. Enzymatic synthesis suffers from low catalytic efficiency, poor regioselectivity, and poor stability of free enzymes, making it difficult to achieve efficient and simplified synthesis.

Method used

The high-performance ligase mutant Q186G/S328A was encapsulated in ZIF-8 metal-organic framework (MOF) material to form an immobilized ligase, which improved its stability and catalytic activity under harsh conditions and facilitated the direct synthesis of α-AMP via L-aspartate-α,β-dimethyl ester and L-phenylalanine.

Benefits of technology

It achieves efficient α-AMP generation, significantly inhibits β-isomer formation, and the immobilized enzyme is easy to recover and reuse, reducing the cost of enzyme use and possessing good potential for industrial applications.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a preparation method and application of metal organic framework immobilized ligase. The immobilized enzyme is prepared by encapsulating a high-performance ligase mutant Q186G / S328A with an amino acid sequence as shown in SEQ ID NO: 2 into a ZIF-8 framework in situ. The immobilized enzyme has high catalytic activity and high alpha-regioselectivity of the mutant and excellent stability brought by ZIF-8 encapsulation. When being used for catalyzing condensation of L-aspartic acid-alpha, beta-dimethyl ester and L-phenylalanine to prepare an aspartame key intermediate alpha-AMP, the alpha-AMP has the conversion rate, selectivity and operation stability which are superior to those of free enzyme, and can be recycled for multiple times while the activity is kept good. The invention provides a brand-new enzyme catalysis process for green, efficient, economical and industrial synthesis of aspartame.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application belongs to the field of biocatalysis and enzyme engineering, and particularly relates to a preparation method of metal-organic framework (MOF) immobilized ligase and application thereof in catalytic synthesis of key intermediate alpha-L-aspartyl-L-phenylalanine-beta-ester (alpha-AMP) of aspartame. BACKGROUND

[0002] Aspartame (alpha-L-aspartyl-L-phenylalanine methyl ester) is a widely used high-intensity artificial sweetener. The traditional chemical synthesis method has a long route, complicated steps, uses dangerous reagents, and more importantly, generates no-sweet beta-isomer by-product, leading to difficult separation and low yield.

[0003] Enzymatic synthesis is concerned due to its high stereoselectivity and mild reaction conditions. Existing enzymatic synthesis methods usually adopt N-protected aspartic acid derivatives and phenylalanine methyl ester for condensation to synthesize N-protected aspartame precursor, and then deprotection to obtain aspartame. Although this route improves selectivity, it increases protection / deprotection steps, and increases raw material cost and process complexity. For example, patents CN97198809.9 and CN201510021876.9 both describe such enzymatic routes requiring protection groups.

[0004] In order to simplify the process, researchers have explored a path for directly synthesizing alpha-AMP, the key intermediate of aspartame, using non-protected aspartic acid derivatives (such as L-aspartic acid-alpha, beta-dimethyl ester) and L-phenylalanine as substrates. However, natural enzymes often face problems such as low catalytic efficiency and low regioselectivity (alpha / beta selectivity) in this reaction. The inventors previously developed a high-performance ligase mutant Q186G / S328A, which has significantly enhanced catalytic activity and alpha-regioselectivity for substrates L-aspartic acid-alpha, beta-dimethyl ester and L-phenylalanine. However, free enzymes often have problems such as poor stability, difficulty in recycling, and the like in industrial applications.

[0005] Metal-organic framework (MOF) materials, such as ZIF-8, are widely used for enzyme immobilization due to their high specific surface area, adjustable pore size, and good biocompatibility. MOF encapsulation can form a protective microenvironment around the enzyme molecules, significantly improving the stability and reusability of the enzyme under harsh conditions. SUMMARY

[0006] The present application aims to overcome the shortcomings of the prior art, and provides a metal-organic framework (MOF) immobilized ligase with high activity and stability and reusability, a preparation method thereof, and application thereof in catalytic synthesis of key intermediate alpha-AMP of aspartame.

[0007] The technical scheme of the present application: A metal organic framework immobilized ligase, wherein the immobilized ligase is formed by encapsulating ligase mutant Q186G / S328A into a ZIF-8 framework, and the amino acid sequence of the ligase mutant Q186G / S328A is shown in SEQ ID NO: 2.

[0008] A method for preparing the metal organic framework immobilized ligase, comprising the following steps: a. preparing a mixed aqueous solution containing zinc ions and 2-methyl imidazole; b. adding an enzyme solution containing the ligase mutant Q186G / S328A into the mixed solution of step a, mixing uniformly and performing a reaction; c. after the reaction is completed, performing solid-liquid separation, collecting the solid product, washing and drying, thereby obtaining the MOF immobilized ligase mutant.

[0009] Preferably, the zinc ions are zinc nitrate, and the molar ratio of zinc ions to 2-methyl imidazole is 1:(4-8); the temperature of the reaction is 15-30℃, and the time is 0.5-2h.

[0010] The application of the metal organic framework immobilized ligase in catalyzing the synthesis of a key intermediate of aspartame, i.e., alpha-L-aspartyl-L-phenylalanine-beta-ester.

[0011] Preferably, the synthesis reaction is performed in a borate buffer solution with a pH of 8-10, using L-aspartic acid-alpha, beta-dimethyl ester and L-phenylalanine as substrates.

[0012] After the reaction is completed, the immobilized enzyme can be separated from the reaction system by centrifugation or filtration, and can be repeatedly used for the next batch of catalytic reactions.

[0013] A method for synthesizing aspartame is provided, comprising the following steps: a. using the immobilized enzyme to catalyze the reaction of L-aspartic acid-alpha, beta-dimethyl ester and L-phenylalanine to generate a reaction solution containing alpha-AMP; b. performing post-treatment on the reaction solution obtained in step a, and separating or in-situ converting the alpha-AMP to obtain aspartame.

[0014] Advantages:

[0015] By in-situ encapsulation of ZIF-8, the immobilized enzyme prepared by the application maintains the high catalytic activity of the ligase mutant Q186G / S328A, and has high relative activity after encapsulation; the MOF encapsulation provides a solid protective layer for the enzyme, greatly enhancing the stability of the enzyme; the immobilized enzyme inherits the advantages of high alpha-region selectivity of the mutant, and can efficiently and specifically generate the target product alpha-AMP in the catalytic reaction, effectively inhibiting the generation of beta-isomer; the immobilized enzyme is easy to separate and recover from the reaction system, without the need for inactivation and protein removal steps, and can be directly used for the next step of chemical conversion to aspartame after simple centrifugation, and can be recycled multiple times. After 15 cycles, it can still maintain more than 80% of the initial activity, significantly reducing the cost of enzyme use, and having good potential for industrial application. DETAILED DESCRIPTION

[0016] In order to better illustrate the purpose, technical scheme and advantages of the application, the following examples are provided to further illustrate the application. It should be understood that the specific examples described herein are only used to explain the application, and the protection scope of the application is not limited thereto.

[0017] Example 1: Preparation of ligase free enzyme By performing three-dimensional structure simulation and docking analysis with substrates on the ligase (CoGb, NCBI accession number MDB4875337.1) derived from Gemmatimonadetes bacterium, rational design method was used to select key sites in the ligase and substrate binding site for site-directed mutagenesis. After mutating glutamine at position 186 to glycine and mutating serine at position 328 to alanine, a ligase mutant Q186G / S328A with improved activity was obtained, and its amino acid sequence is shown as SEQ ID NO. 2. The recombinant genetically engineered bacteria E. coli BL21-pET28a-Q186G / S328A containing the ligase mutant gene (optimized by codon) were obtained by direct synthesis by Nanjing Kingsrui Biological Technology Co., Ltd., and were preserved in a ultra-low temperature refrigerator at -80℃.

[0018] The recombinant bacteria E. coli described above were inoculated into 10 ml of LB medium containing kanamycin (50 ug / mL), and cultured at 37°C for 12 h, then transferred to 400 ml of TB fermentation medium at a 2% inoculation amount, and first incubated at 37°C, 200 rpm to a bacterial OD600 of 0.6, then transferred to 30°C, 200 rpm for shake flask induction fermentation for 18 h. After fermentation, the bacterial cells were collected by centrifugation at 8000 rpm for 5 min. 4 g of wet bacterial cells after fermentation were weighed, resuspended in 40 ml of 50 mM Tris pH 8.0 buffer, and then ultrasonically broken (ultrasonic 1 s, stop 2 s, 20 min) and centrifuged at 8000 rpm for 20 min. The supernatant was the crude enzyme solution of the ligase mutant Q186G / S328A.

[0019] Example 2: Detection of free enzyme activity of ligase mutant Q186G / S328A Take 5 ml EP tubes, add 0.1 mL of the crude enzyme solution of the ligase mutant in the above example, and then add 1.9 mL of the pre-prepared substrate reaction solution, which contains: 0.1 M borate buffer (pH 9.0), 200 mM L-aspartate-α, β-dimethyl ester hydrochloride, 400 mM L-phenylalanine, and 20 mM EDTA. Mix the mixed system gently, and then place it in a 30°C constant temperature water bath for reaction for 6 h. Add an equal volume of 2 ml of acetonitrile to terminate the reaction, vortex to precipitate the protein, and then centrifuge at 12,000 rpm for 5 min, and then take the supernatant for HPLC analysis to quantitatively detect the generated α-AMP. The results show that after 6 h of reaction, the yield of α-AMP catalyzed by the mutant Q186G / S328A is 95%, no β-isomer by-product is detected, and the content of α-AMP no longer increases. The yield of α-AMP catalyzed by the original ligase is 45%, and the enzyme activity is increased by 2.1 times after mutation.

[0020] Example 3: Preparation of metal-organic framework immobilized ligase mutant Q186G / S328A@ZIF-8 Weigh 0.293 g of Zn(NO3)2·6H2O and 0.324 g of 2-methylimidazole, and dissolve them in 5 mL of ultrapure water, respectively. Pour the 2-methylimidazole solution into the zinc salt solution quickly, and mix well. Then, quickly add 2 mL of crude enzyme solution containing about 20 mg of ligase mutant Q186G / S328A to the above mixture, vortex to mix, and let stand at room temperature for 1 hour. After the reaction is completed, collect the white precipitate by centrifugation at 8000 rpm for 5 min, wash it with ultrapure water three times, and dry it in a vacuum drying oven at 40°C overnight to obtain white powder enzyme@ZIF-8 immobilized enzyme, which is stored at 4°C for standby use.

[0021] Example 4: Enzyme loading and encapsulation efficiency determination of Q186G / S328A@ZIF-8 The protein content was determined by BCA method, and the initial protein amount was 4.00 mg. The supernatant and washing liquid during the encapsulation process were collected, and the total residual protein amount was 0.68 mg.

[0022] Encapsulation efficiency = (4.00 - 0.68) / 4.00 x 100% = 83.0% The mass of Q186G / S328A@ZIF-8 solid after drying was 112 mg Protein loading = (4.00 - 0.68) / 0.112 = 29.7 mg / g Enzyme activity definition: The amount of enzyme required to produce 1 μmol of α-AMP per minute at 20°C and pH 9.0 is defined as one unit of activity (U). The relative enzyme activity of the immobilized enzyme was compared to the enzyme activity of the free enzyme, which was taken as 100%.

[0023] According to the free enzyme activity determination method of Example 2, the relative activity of the encapsulated enzyme was 82.5% compared to the free enzyme, using equal amounts of enzyme for activity determination.

[0024] Example 5: Application of immobilized enzyme Q186G / S328A@ZIF-8 in the catalytic preparation of α-AMP, an intermediate for aspartame A 20 mL reaction system was set up in a 50 mL shaking tube, using 0.1 M, pH 9.0 borate buffer, and adding 200 mM L-aspartic acid-α, β-dimethyl ester hydrochloride, 400 mM L-phenylalanine, and 20 mM EDTA. 100 mg of enzyme@ZIF-8 solid was added, and the reaction was allowed to stand in a 30°C constant temperature water bath. Every 1 h, 1 ml was sampled, centrifuged at 12,000 rpm for 5 minutes, and the supernatant was analyzed by HPLC. After 6 h, the α-AMP yield was more than 95% and did not change. The entire reaction solution was centrifuged at 12,000 rpm for 5 min, and the supernatant was directly used for subsequent chemical conversion of aspartame.

[0025] After each round of reaction, the Q186G / S328A@ZIF-8 solid recovered by centrifugation was washed twice with acetonitrile, and then new substrate solution was added for the next round of reaction. After 15 cycles, it still maintained more than 80% of the initial activity.

[0026] Example 6: Preparation of aspartame by chemical conversion The supernatant reaction solution of the first round was cooled in an ice-water bath, and 1 M sodium hydroxide solution was slowly added dropwise under stirring, and the pH value of the reaction system was accurately adjusted to 10.0. Under this alkaline condition, the reaction was kept at low temperature (0-5°C) and continuously stirred for 4 hours, and HPLC was used for monitoring until the peak area of the intermediate α-AMP was substantially unchanged. After the reaction was completed, 1 M hydrochloric acid solution was slowly added dropwise under stirring, and the pH value of the mixture was carefully adjusted to the isoelectric point of aspartame (pH 5.2), at which time a large amount of white crystals, i.e. aspartame, was precipitated. The suspension was placed at 4°C for aging overnight to complete the crystallization, and finally the crystals were collected by suction filtration and washed with ice-cold ultrapure water and ethanol in sequence, and the obtained white crystals were vacuum dried at 40°C for 6 hours, thereby obtaining the high-purity aspartame (α-APM) final product, with a yield of 84%. According to the same chemical conversion method, the supernatant of the intermediate α-AMP reaction solution catalyzed by the immobilized enzyme Q186G / S328A@ZIF-8 in each round was continuously converted to aspartame, thereby continuously obtaining a large amount of aspartame final product.

[0027] The above-described embodiments are merely preferred embodiments of the present application, and are not intended to limit the protection scope of the present application. Any modifications, equivalent replacements, and improvements within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A metal-organic framework-immobilized ligase, characterized in that, The immobilized ligase is composed of a ligase mutant Q186G / S328A encapsulated in a ZIF-8 framework; the amino acid sequence of the ligase mutant Q186G / S328A is shown in SEQ ID NO:

2.

2. A method of preparing the metal organic framework immobilized ligase of claim 1, wherein, The method comprises the following steps: a. preparing a mixed aqueous solution containing zinc ions and 2-methylimidazole; b. adding an enzyme solution containing the ligase mutant Q186G / S328A to the mixed solution of step a, mixing uniformly and performing a reaction; c. after the reaction is completed, solid-liquid separation is performed, the solid product is collected, washed and dried, thereby obtaining the MOF immobilized ligase mutant Q186G / S328A@ZIF-8.

3. The method of claim 2, wherein, The zinc ions are zinc nitrate, and the molar ratio of zinc ions to 2-methylimidazole is 1:(4-8); the reaction temperature is 15-30°C, and the reaction time is 0.5-2h.

4. Use of the metal organic framework immobilized ligase according to claim 1 in catalyzing synthesis of a key intermediate of aspartame, α-L-aspartyl-L-phenylalanine-β-ester.

5. The use according to claim 4, wherein the compound is ###0002### The synthesis reaction uses L-aspartic acid-α,β-dimethyl ester and L-phenylalanine as substrates and is performed in a borate buffer solution at pH 8-10.

6. The use according to claim 4, wherein the compound is ###0002### After the catalytic reaction is completed, the immobilized ligase Q186G / S328A@ZIF-8 can be separated from the reaction system by centrifugation or filtration and recycled for use in the next batch of catalytic reactions.

7. The use according to claim 4, wherein the compound is ###0002### The metal organic framework immobilized ligase Q186G / S328A@ZIF-8 retains at least 80% activity after being recycled for use for 15 times or more.

8. A method of synthesizing aspartame, characterized by, The method comprises the following steps: a. using the metal organic framework immobilized ligase Q186G / S328A@ZIF-8 according to claim 1 to catalyze the reaction of L-aspartic acid-α,β-dimethyl ester and L-phenylalanine to generate a reaction solution containing α-AMP; b. removing the immobilized enzyme after the reaction solution obtained in step a is subjected to separation or filtration treatment, and chemically converting the α-AMP in situ to obtain aspartame.

Citation Information

Patent Citations

  • A process for the efficient enzymatic synthesis of benzyloxycarbonyl aspartame

    CN104774891B

  • Enzymatic method for producing N-formyl-alpha-L-aspartyl-L-phenyalanine methyl ester

    CN1236371A